Neon Therapeutics Investors

16 investors on Angel Roster list Neon Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States and Switzerland.

Investors are matched on the company name in their portfolio, so companies that share the name Neon Therapeutics can appear together.

Investors listed
16
With verified email
31%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 Neon Therapeutics investors

The most complete profiles first. Showing 16 of 16.

  • Christoph LengauerVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Craig MuirVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Eli CasdinVerified

    Venture Capital, Founder, Micro VC · United States

    SeedHealth CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more

    Verified email available

  • Robert TepperVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Noreen RizviVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Verified email available

  • Abbie Celniker

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more

    Contact details available

  • Cary Pfeffer

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • George Xu

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Mark Levin

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceEducation

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Neil Exter

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Thomas Lips

    Venture Capital, Private Equity Firm, Investor · Switzerland

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more

    Contact details available

  • Adeline Oursler

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Cody Tranbarger

    Micro VC · United States

    Health CareGeneticsWellnessWomen Founded

    Portfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more

    Contact details available

  • Kelly Moynihan

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • Walter Kowtoniuk

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

  • William Motley

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more

    Contact details available

Frequently asked questions

How many Neon Therapeutics investors are on Angel Roster?

Angel Roster lists 16 Neon Therapeutics investors. 5 of them (31%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (14), Private Equity Firms (7) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Neon Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (10).

Where are Neon Therapeutics investors based?

Most are based in the United States (15) and Switzerland (1).

Which companies have Neon Therapeutics investors backed?

The most-backed portfolio companies among them are MOMA Therapeutics (16), Revolution Medicines (16), Jounce Therapeutics (16), Tango Therapeutics (15) and Relay Therapeutics (15).

How do I contact Neon Therapeutics investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.